Stella Pharma Corporation (TYO:4888)

Stella Pharma Statistics

Total Valuation

Stella Pharma has a market cap or net worth of JPY 10.69 billion. The enterprise value is 8.58 billion.

Market Cap	10.69B
Enterprise Value	8.58B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Stella Pharma has 34.03 million shares outstanding. The number of shares has increased by 6.40% in one year.

Current Share Class	34.03M
Shares Outstanding	34.03M
Shares Change (YoY)	+6.40%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	4.28%
Owned by Institutions (%)	-0.42%
Float	20.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.77
PB Ratio	3.69
P/TBV Ratio	3.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-47.91
EV / Sales	8.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.67

Financial Position

The company has a current ratio of 16.63, with a Debt / Equity ratio of 0.24.

Current Ratio	16.63
Quick Ratio	11.92
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-0.93
Interest Coverage	-24.00

Financial Efficiency

Return on equity (ROE) is -5.99% and return on invested capital (ROIC) is -2.00%.

Return on Equity (ROE)	-5.99%
Return on Assets (ROA)	-1.48%
Return on Invested Capital (ROIC)	-2.00%
Return on Capital Employed (ROCE)	-2.59%
Weighted Average Cost of Capital (WACC)	9.54%
Revenue Per Employee	23.07M
Profits Per Employee	-4.16M
Employee Count	43
Asset Turnover	0.20
Inventory Turnover	0.11

Taxes

In the past 12 months, Stella Pharma has paid 2.00 million in taxes.

Income Tax	2.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.84% in the last 52 weeks. The beta is 1.07, so Stella Pharma's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-30.84%
50-Day Moving Average	252.34
200-Day Moving Average	336.56
Relative Strength Index (RSI)	57.98
Average Volume (20 Days)	2,456,850

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stella Pharma had revenue of JPY 992.00 million and -179.00 million in losses. Loss per share was -5.26.

Revenue	992.00M
Gross Profit	863.00M
Operating Income	-120.00M
Pretax Income	-177.00M
Net Income	-179.00M
EBITDA	-89.00M
EBIT	-120.00M
Loss Per Share	-5.26

Balance Sheet

The company has 2.80 billion in cash and 686.00 million in debt, with a net cash position of 2.11 billion or 62.03 per share.

Cash & Cash Equivalents	2.80B
Total Debt	686.00M
Net Cash	2.11B
Net Cash Per Share	62.03
Equity (Book Value)	2.90B
Book Value Per Share	85.20
Working Capital	4.49B

Cash Flow

In the last 12 months, operating cash flow was -725.00 million and capital expenditures -10.00 million, giving a free cash flow of -735.00 million.

Operating Cash Flow	-725.00M
Capital Expenditures	-10.00M
Free Cash Flow	-735.00M
FCF Per Share	-21.60

Margins

Gross margin is 87.00%, with operating and profit margins of -12.10% and -18.04%.

Gross Margin	87.00%
Operating Margin	-12.10%
Pretax Margin	-17.84%
Profit Margin	-18.04%
EBITDA Margin	-8.97%
EBIT Margin	-12.10%
FCF Margin	n/a

Dividends & Yields

Stella Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.40%
Shareholder Yield	-6.40%
Earnings Yield	-1.67%
FCF Yield	-6.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stella Pharma has an Altman Z-Score of 5.47 and a Piotroski F-Score of 3.

Altman Z-Score	5.47
Piotroski F-Score	3